INMED PHARMACEUTICALS INC. Inventory Valuation Reserves
INMED PHARMACEUTICALS INC. (INM) had Inventory Valuation Reserves of $278.74 thousand as of 2025-12-31, per its 10-Q filed 2026-02-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryValuationReserves · last filed 2026-07-02
- 2025-12-31: Inventory Valuation Reserves $278.74K.
- 2025-06-30: Inventory Valuation Reserves $208.74K.
- 2025-03-31: Inventory Valuation Reserves $103.43K.
- 2024-12-31: Inventory Valuation Reserves $103.43K.
| Period end | Inventory Valuation Reserves |
|---|---|
| 2025-12-31 | $278.74K 10-Q · filed 2026-02-11 |
| 2025-06-30 | $208.74K 10-Q · filed 2026-02-11 |
| 2025-03-31 | $103.43K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $103.43K 10-Q · filed 2025-02-12 |
| 2024-06-30 | $103.43K S-4 · filed 2026-07-02 |
| 2023-09-30 | $186.75K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $93.82K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |